FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Propofol Injectable Emulsion Recall

Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 20…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Oct 3, 2012
Recall ID
D-1685-2012
Check your lot numberHow we source this data

Summary

Hospira recalled Propofol Injectable Emulsion starting Aug 29, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1685-2012 on Oct 3, 2012. Reason: Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.

Product description

Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 50 mL Single patient infusion vial, 500 mg/50 mL (10 mg/mL), NDC 0409-4699-33; c) 100 mL Single patient infusion vial, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA

Lot numbers, UPCs & expiration codes

Lot No: a) 93-857-DJ, 93-896-DJ, Exp 1SEP2012; 04-515-DJ, Exp 1APR2013; 06-802-DJ, Exp 1JUN2013; b) 01-175-DJ, Exp 1JAN2013; 04-565-DJ, Exp 1APR2013; c) 03-388-DJ, Exp 1MAR2013; The lot number may be followed by 01 or 02

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1685-2012
Classification
Class II
Status
Terminated
Recall initiated
Aug 29, 2012
FDA report date
Oct 3, 2012
Quantity
148,630 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1685-2012, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
63198
Address
275 N Field Dr
Code information
Lot No: a) 93-857-DJ, 93-896-DJ, Exp 1SEP2012; 04-515-DJ, Exp 1APR2013; 06-802-DJ, Exp 1JUN2013; b) 01-175-DJ, Exp 1JAN2013; 04-565-DJ, Exp 1APR2013; c) 03-388-DJ, Exp 1MAR2013; The lot number may be followed by 01 or 02
Postal code
60045-2579
Report date
Oct 3, 2012
Product type
Drugs
Recall number
D-1685-2012
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
148,630 vials
Termination date
Aug 8, 2013
Reason for recall
Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 50 mL Single patient infusion vial, 500 mg/50 mL (10 mg/mL), NDC 0409-4699-33; c) 100 mL Single patient infusion vial, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA
Distribution pattern
Nationwide
Recall initiation date
Aug 29, 2012
Initial firm notification
Letter
Center classification date
Sep 21, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1685-2012, published Oct 3, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls